282 related articles for article (PubMed ID: 27050297)
1. Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer's disease mice.
Qiu L; Ng G; Tan EK; Liao P; Kandiah N; Zeng L
Sci Rep; 2016 Apr; 6():23964. PubMed ID: 27050297
[TBL] [Abstract][Full Text] [Related]
2. Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia.
Koike MA; Garcia FG; Kitazawa M; Green KN; Laferla FM
Neurosci Lett; 2011 May; 495(1):55-9. PubMed ID: 21419194
[TBL] [Abstract][Full Text] [Related]
3. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model.
Kim S; Lee D; Song JC; Cho SJ; Yun SM; Koh YH; Song J; Johnson GV; Jo C
Biochem Biophys Res Commun; 2014 Nov; 454(1):196-201. PubMed ID: 25450380
[TBL] [Abstract][Full Text] [Related]
4. Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
Neves AF; Camargo C; Premer C; Hare JM; Baumel BS; Pinto M
Exp Neurol; 2021 Jul; 341():113706. PubMed ID: 33757765
[TBL] [Abstract][Full Text] [Related]
5. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
6. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
[TBL] [Abstract][Full Text] [Related]
7. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
Bories C; Arsenault D; Lemire M; Tremblay C; De Koninck Y; Calon F
Aging (Albany NY); 2017 May; 9(5):1386-1403. PubMed ID: 28522792
[TBL] [Abstract][Full Text] [Related]
8. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
9. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
[TBL] [Abstract][Full Text] [Related]
11. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
[TBL] [Abstract][Full Text] [Related]
12. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
13. Twendee X Ameliorates Phosphorylated Tau, α-Synuclein and Neurovascular Dysfunction in Alzheimer's Disease Transgenic Mice With Chronic Cerebral Hypoperfusion.
Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104310. PubMed ID: 31383622
[TBL] [Abstract][Full Text] [Related]
14. Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice.
Huang HJ; Chen SL; Huang HY; Sun YC; Lee GC; Lee-Chen GJ; Hsieh-Li HM; Su MT
Psychopharmacology (Berl); 2019 Feb; 236(2):763-773. PubMed ID: 30426182
[TBL] [Abstract][Full Text] [Related]
15. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
[TBL] [Abstract][Full Text] [Related]
16. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
17. Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
Lee JI; Lim JS; Hong JH; Kim S; Lee SW; Ji HD; Won KS; Song BI; Kim HW
PLoS One; 2022; 17(2):e0262224. PubMed ID: 35143502
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
[TBL] [Abstract][Full Text] [Related]
19. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}.
Koike MA; Green KN; Blurton-Jones M; Laferla FM
Am J Pathol; 2010 Jul; 177(1):300-10. PubMed ID: 20472896
[TBL] [Abstract][Full Text] [Related]
20. Chronic cerebral hypoperfusion upregulates leptin receptor expression in astrocytes and tau phosphorylation in tau transgenic mice.
Shimada T; Shindo A; Matsuyama H; Yata K; Niwa A; Sasaki R; Ayaki T; Maki T; Wakita H; Tomimoto H
Neurosci Lett; 2019 Jun; 704():133-140. PubMed ID: 30954605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]